Amgen Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
167 result(s) found, displaying 21 to 30
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WEZLANA ustekinumab 45 mg / 0.5 mL solution for subcutaneous injection pre-filled syringe.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Australian Public Assessment Report (AusPAR)Wezlana (ustekinumab) has been approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
-
May-2024Prescription medicine evaluationActive ingredient: inebilizumab.